Singapore, Aug. 7 -- XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, has announced a transformative strategic collab... Read More
Singapore, Aug. 7 -- India-based Intas Pharmaceuticals, in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's leading suppli... Read More
Singapore, Aug. 7 -- Intrinseque Health is setting foundation of a first-of-its-kind GMP Warehouse in Melaka, Malaysia. First announced by Nitin Jain, President & CEO at Intrinseque Health, during his... Read More
Singapore, Aug. 6 -- Scientists fromCommonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency, have developed a world-first method to teach artificial i... Read More
Singapore, Aug. 6 -- Nanyang Technological University, Singapore (NTU Singapore) and the National University of Singapore (NUS) are renewing their commitment to share high-value research equipment and... Read More
Singapore, Aug. 6 -- Two leading scientific organisationsbased in Korea, the Korea Disease Control and Prevention Agency (KDCA) and International Vaccine Institute (IVI), are joining the world's large... Read More
Singapore, Aug. 5 -- The Asian Development Bank (ADB) and the Drugs for Neglected Diseases initiative (DNDi) have signed a Memorandum of Understanding (MoU) to formalise a non-exclusive framework of c... Read More
Singapore, Aug. 5 -- Body Vision Medical, a leader in artificial intelligence (AI)-powered intraoperative imaging, has announcde that its LungVision advanced imaging platform has received Pre-Market A... Read More
Singapore, Aug. 5 -- Australia's Monash University has launched theMonash Ventures Pre-Seed Fund, a $15 million initiative developed in partnership with Breakthrough Victoria to support the commercial... Read More
Singapore, Aug. 5 -- Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead created ... Read More